Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized placebo controlled trial assessing the efficacy and safety of BP1.4979 in smoking cessation
2012-002731-28Phase 2Completed
- Sponsor
- Bioprojet
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in nicotine dependence comparing BP1.4979 with Placebo (2 arms). Primary endpoint: 4-week prolonged smoking abstinence at end of treatment. Started Sep 2012; status: completed.
02
Drugs
BP-1.4979
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on 2012-002731-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002731-28.